Norverapamil hydrochloride,
67812-42-4,
Norverapamil, Hydrochloride,
Norverapamil (hydrochloride),
Nor Verapamil Hydrochloride,
( inverted exclamation markA)-Norverapamil hydrochloride,
C26H36N2O4,
(S)-(-)-Nor Verapamil Hydrochloride,
OEAFTRIDBHSJDC-UHFFFAOYSA-N,
AC1L4DFF,
Norverapamil(hydrochloride),
CHEMBL3526876,
CTK8G2014,
KS-00001COQ,
AKOS030242657,
API0008846,
CS-5985,
Benzeneacetonitrile, alpha-(3-((2-(3,4-dimethoxyphenyl)ethyl)amino)propyl)-3,4-dimethoxy-alpha-(1-methylethyl)-, monohydrochloride,
HY-100750,
FT-0673152,
Z3358,
BIM-0061759.0001,
(+/-)-Norverapamil hydrochloride, >=98% (HPLC),
N-Nor-( inverted exclamation markA)-verapamil hydrochloride,
(+/-)-Norverapamill hydrochloride solution, 1.0 mg/mL in methanol (as free base), ampule of 1 mL, certified reference material,
2-(3,4-dimethoxyphenyl)-5-[2-(3,4-dimethoxyphenyl)ethylamino]-2-propan-2-ylpentanenitrile hydrochloride,
2-(3,4-dimethoxyphenyl)-5-[2-(3,4-dimethoxyphenyl)ethylamino]-2-propan-2-ylpentanenitrile;hydrochloride,
alpha-(3-((2-(3,4-Dimethoxyphenyl)ethyl)methylamino)propyl)-3,4-dimethoxy-alpha-(1-methylethyl)-benzeneacetonitrile hydrochloride,
Norverapamil,
Verapamil hydrochloride,
C26-H36-N2-O4.Cl-H,
(R)-(+)-Norverapamil Hydrochloride,
(S)-(-)-Norverapamil Hydrochloride,
CID155002,
(+/-)-VERAPAMIL HYDROCHLORIDE,
CS-O-05893,
67018-85-3,
123931-31-7,
|A-[3-[[2-(3,4-Dimethoxyphenyl)ethyl]amino]propyl]-3,4-dimethoxy-|A-(1-methylethyl)-benzeneacetonitrile,
123932-43-4,
152-11-4,
5-[N-(3,4-Dimethoxyphenylethyl)methylamino]-2-(3,4-dimethoxyphenyl)-2-isopropylvaleronitrile hydrochloride,